It also provides pharmaceutically acceptable ingredients containing compounds and methods of use of ingredients for the treatment of bacterial infections and processes. 1. Claim 1: a formula compound (1),Or a salt acceptable for a medicament containing x-or831111；And it is absent or is an aliphatic C₁₋₁₀ where up to four methylene units of the aliphatic C₁₋₁₀ can optionally be replaced by -NR⁸,- that is...- yes.-C (O) --S (O) -O-SO8322-；And it is optionally substituted by 1-2 cases of halogen, OH, C₃₋₆ cycloalkyl or C₁₋₆ aliphatic；R¹ is aryl C₆₋₁₀ optionally substituted by one or more R³A groups； and R² is H, C₃₋₆ cycloalkyl,3-8 membered heterocyclyl, C₆₋₁₀ aryl,(Aril C) - (alquilo C) -O heteromorphism consisting of 5-10 members； each R2 km is replaced by one or more R3 B groups independently and optionally by one R3 group；Each R3a and R3b is an independent halogen.C₃₋₆ cycloalkyl,3-8 membered heterocyclyl, (C ar aryl) - (C₁₋₆ alkyl) -,or an aliphatic C₁₋₁₀ where up to four methylene units of the aliphatic C₁₋₁₀ can optionally be replaced by -NR⁴,- that is...- yes.-C (O) --S (O) --SO₂-,That's it, that's it.each R³A and R³B is independently and optionally substituted by one or more R⁴ or R⁴A groups； R³ is C₃₋₆ cycloalkyl,3-8 membered heterocyclyl, C₆₋₁₀ aryl,(Cil aryl) - (C₁₋₆ alkyl) or 5-10 membered heteroaryl； each R³ is optionally substituted by one or more R⁴ or R⁴A groups； R⁴ is H, C₁₋₆ alkyl,C₁₋₆ alkenyl,C₁₋₆ alkynyl,C₃₋₈ cycloalkyl,3-8 membered heterocyclyl, C₆₋₁₀ aryl or 5-10 membered heteroaryl； each R⁴ is optionally substituted by one or more R⁴B groups； R⁴A is halogen, CN, NO₂,or an aliphatic C₁₋₁₀ where up to four methylene units of the aliphatic C₁₋₁₀ can optionally be replaced by -NR⁴,- that is...- yes.- C (O) --S (O) --SO₂-,That's it, that's it.Each r83088a can be replaced by 1-3 halogen； r83088b is halogen, CN, no.8322；or an aliphatic C₁₋₁₀ where up to four methylene units of the aliphatic C₁₋₁₀ can optionally be replaced by -NR, -O-,- yes.-C (O) -S (
